NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biodimension

Biodimension

Private
BangaloreHealthcare & Life Scienceshttps://biodimension.in/

Last Round

Seed

Jun 11, 2026

Total Funding Raised

$984,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Biodimension is a biotechnology company that develops biofabricated human tissue and organoid models as alternatives to animal testing for pharmaceutical, biotechnology, and cosmetic companies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Fashion & Beauty, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

human tissue modelsorganoidsbioassay as a serviceanimal testing alternativedrug discovery servicesbiofabricationorgan-on-a-chip3D cell culturein vitro testingsafety assessment3D bioprintingcosmetic testingskin tissue modelscontract research servicescruelty-free testingcancer biobanktissue engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biodimension Comparables

Compare Biodimension with similar companies based on industry and business-model similarity.

Biodimension comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Biodimension Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 11, 2026
SeedOct 16, 2024

Key People

Founding team and executive leadership

Manojkumar Sampathkumar

Co-Founder and CEO

Founding Team

Biodimension Investors

Notable investors and investment history

Biodimension investors
InvestorRounds
IAN GroupSeed
Campus Angels NetworkSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 704% MoM, reaching 15.9K.

  • Jun 11, 2026

    $912K round led by Ian Angel Fund.

Biodimension Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biodimension Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biodimension's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range13
Year Founded2021
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.